Purchases and Sales Made in Q4 2022 in Unicycive Therapeutics, Inc. (UNCY)
This table provides information about the institutional ownership of Unicycive Therapeutics, Inc. (UNCY) during Q4 2022. The information is specifically focused on institutions that hold shares of Unicycive Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
15.5KNew |
$7.73K - $12.1K
|
15.5K
$12.5K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
10New |
$5 - $7.8
|
10
$8.1
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 2.22% |
$0.5 - $0.78
|
46
$37.3
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-181- 3.5% |
$90.5 - $141
|
5K
$4.05K
|
|
|
Feb 14, 2023
Q4 2022
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-63.1K- 8.88% |
$31.6K - $49.2K
|
647K
$524K
|